ArticleCureus2026
Localized Epithelioid Peritoneal Mesothelioma: A Rare Mimicker of Gynecological Malignancy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Localized epithelioid peritoneal mesothelioma (LEPM) is a rare variant of peritoneal mesothelioma that presents as a solitary, circumscribed mass rather than with the diffuse serosal spread that characterizes the far more common diffuse form. Because it may arise in the pelvis and be accompanied by ascites and a mildly elevated carbohydrate antigen (CA)-125 level, it is readily mistaken for a gynecological or primary peritoneal malignancy. Although it is generally regarded as less aggressive than the diffuse form, its clinical behavior can be unpredictable. We report the case of a 76-year-old woman in whom a 5 cm pelvic mass was detected incidentally on transvaginal ultrasound and was initially suspected to be a gynecological malignancy. Preoperative MRI demonstrated clear cleavage planes between the mass and the uterus and left ovary, indicating a non-gynecological origin, and surgery confirmed the presence of a tumor on the antimesenteric border of the small bowel. Histopathology, supported by a targeted immunohistochemical panel (showing calretinin, WT1, D2-40, and CK7 positivity and loss of BAP1), established the diagnosis of LEPM. Despite an apparently localized presentation and complete resection, early peritoneal recurrence developed on follow-up imaging, prompting adjuvant systemic therapy and cytoreductive surgery (CRS). This report underscores that LEPM should be considered in the differential diagnosis of a solitary pelvic mass, highlights the importance of cross-sectional imaging combined with a specific immunohistochemical panel for distinguishing it from gynecological tumors and gastrointestinal stromal tumor (GIST), and emphasizes the need for close follow-up even when the disease appears localized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.